Elan Subpoenaed By SEC Over Drug Disclosures
Irish pharmaceutical company Elan Corp. said Tuesday it had received a subpoena from the U.S. Securities and Exchange Commission requesting details on company disclosures about multiple sclerosis drug Tysabri and an...To view the full article, register now.
Already a subscriber? Click here to view full article